Friday, June 03, 2022 9:30:08 AM
👉Tecovirimat is an #antiviral authorised to treat smallpox, #monkeypox and cowpox.
— EU Medicines Agency (@EMA_News) June 2, 2022
👉Imvanex is a vaccine currently only authorised in the 🇪🇺 to protect adults against smallpox, but animal data show effectiveness in the prevention of monkeypox.
Recent SIGA News
- Form SC 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 11/08/2024 10:31:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2024 09:55:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2024 09:05:47 PM
- SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2024 • GlobeNewswire Inc. • 11/07/2024 09:05:00 PM
- SIGA to Host Business Update Call on November 7 Following Release of Third-Quarter 2024 Financial Results • GlobeNewswire Inc. • 10/31/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/29/2024 09:03:36 PM
- SIGA Enters into Exclusive License Agreement with Vanderbilt University for Novel Poxvirus Monoclonal Antibodies • GlobeNewswire Inc. • 10/22/2024 11:30:00 AM
- SIGA Announces Agreement to Supply TPOXX® in Morocco • GlobeNewswire Inc. • 10/08/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/04/2024 08:07:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/23/2024 08:05:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/20/2024 08:07:46 PM
- SIGA Announces New Contract Awarded by U.S. Department of Defense for the Procurement of $9 Million of TPOXX® • GlobeNewswire Inc. • 08/21/2024 08:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/15/2024 11:40:18 AM
- Topline Results from PALM 007 Study of SIGA’s Tecovirimat in Treatment of Mpox Released • GlobeNewswire Inc. • 08/15/2024 11:35:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/01/2024 08:59:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 08:06:09 PM
- SIGA Reports Financial Results for Three and Six Months Ended June 30, 2024 • GlobeNewswire Inc. • 08/01/2024 08:05:00 PM
- SIGA to Host Business Update Call on August 1 Following Release of Second-Quarter 2024 Financial Results • GlobeNewswire Inc. • 07/25/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/19/2024 12:05:49 PM
- SIGA Announces U.S. Government Procurement Order of $113 Million for Oral TPOXX® • GlobeNewswire Inc. • 07/19/2024 12:00:00 PM
- SIGA Announces Agreement to Sell TPOXX® to ASEAN Member States • GlobeNewswire Inc. • 06/17/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 08:28:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 08:23:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 08:21:02 PM
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM